Form 4: Thermo Fisher Scientific CEO Marc Casper Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4
Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares on February 29, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On February 29, 2024, Marc N. Casper, Chairman and CEO of Thermo Fisher Scientific, exercised stock options to acquire 10,000 shares of common stock at a price of $190.59 per share.
- Following the exercise, Casper sold a total of 9,994 shares of common stock in multiple transactions at prices ranging from $568.67 to $573.85 per share.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on November 10, 2023.
- After these transactions, Casper directly owns 125,816.462 shares of Thermo Fisher Scientific common stock.
- Casper also indirectly owns shares through the Alison Casper 2020 Irrevocable Trust (11,300 shares), Floral Park Associates, Inc. (43,608 shares), and the MNC 2020 Irrevocable Trust (5,000 shares).
- He also holds options to buy 86,300 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction under a pre-arranged plan. There's no indication of positive or negative implications for the company's performance.
Positives
- The use of a pre-arranged 10b5-1 trading plan suggests that the transactions were planned and not based on insider information.
Industry Context
Executive stock transactions are common and closely monitored, especially in publicly traded companies like Thermo Fisher Scientific. The use of 10b5-1 plans is a standard practice to avoid insider trading concerns.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a form of long-term incentive.
- The use of Rule 10b5-1 trading plans is a common practice among executives at publicly traded companies to manage their stock holdings and avoid accusations of insider trading.
- Comparable companies like Danaher, Agilent, and Roche also see regular Form 4 filings from their executives related to stock transactions.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| 03/07/2021 | Date stock option became exercisable |
| November 10, 2023 | Date of adoption of Rule 10b5-1 trading plan |
| 02/29/2024 | Date of stock option exercise and share sales |
| 09/07/2024 | Expiration date of stock option |
| 03/04/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.